John H. Sampson

Publications

• Proteomic Profiling of Patient-derived Glioblastoma Xenografts Identifies a Subset with Activated EGFR: Implications for Drug Development
  Journal of Neurochemistry. Jan, 2015  |   Pubmed ID: 25598002
• A Phase II, Multicenter Trial of Rindopepimut (CDX-110) in Newly Diagnosed Glioblastoma: the ACT III Study
  Neuro-oncology. Jan, 2015  |   Pubmed ID: 25586468
• Increased Proportion of FoxP3+ Regulatory T Cells in Tumor Infiltrating Lymphocytes is Associated with Tumor Recurrence and Reduced Survival in Patients with Glioblastoma
  Cancer Immunology, Immunotherapy : CII. Jan, 2015  |   Pubmed ID: 25555571
• Enhancing Dendritic Cell-based Vaccination for Highly Aggressive Glioblastoma
  Expert Opinion on Biological Therapy. Jan, 2015  |   Pubmed ID: 25327832
• Chimeric Antigen Receptor Engineered T Cells Can Eliminate Brain Tumors and Initiate Long-term Protection Against Recurrence
  Oncoimmunology. 2014  |   Pubmed ID: 25610729
• Leveraging Chemotherapy-induced Lymphopenia to Potentiate Cancer Immunotherapy
  Oncoimmunology. 2014  |   Pubmed ID: 25610727
• Peptide Vaccines for the Treatment of Glioblastoma
  Journal of Neuro-oncology. Dec, 2014  |   Pubmed ID: 25491947
• Defining the Optimal Planning Target Volume in Image-Guided Stereotactic Radiosurgery of Brain Metastases: Results of a Randomized Trial
  International Journal of Radiation Oncology, Biology, Physics. Oct, 2014  |   Pubmed ID: 25442342
• Immunotherapy for Primary Brain Tumors: No Longer a Matter of Privilege
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2014  |   Pubmed ID: 25398845
• Severe Adverse Immunologic Reaction in a Patient with Glioblastoma Receiving Autologous Dendritic Cell Vaccines Combined with GM-CSF and Dose-Intensified Temozolomide
  Cancer Immunology Research. Nov, 2014  |   Pubmed ID: 25387895
• Targeting MiR-23a in CD8+ Cytotoxic T Lymphocytes Prevents Tumor-dependent Immunosuppression
  The Journal of Clinical Investigation. Dec, 2014  |   Pubmed ID: 25347474
• Epidermal Growth Factor Receptor and Variant III Targeted Immunotherapy
  Neuro-oncology. Oct, 2014  |   Pubmed ID: 25342601
• Recurrent Malignant Gliomas
  Seminars in Radiation Oncology. Oct, 2014  |   Pubmed ID: 25219814
• Immunotherapy Advances for Glioblastoma
  Neuro-oncology. Nov, 2014  |   Pubmed ID: 25190673
• Rindopepimut: a Promising Immunotherapeutic for the Treatment of Glioblastoma Multiforme
  Immunotherapy. Jun, 2014  |   Pubmed ID: 25186601
• Antibody-based Immunotherapy for Malignant Glioma
  Seminars in Oncology. Aug, 2014  |   Pubmed ID: 25173142
• Standard of Care and Future Pharmacological Treatment Options for Malignant Glioma: an Urgent Need for Screening and Identification of Novel Tumor-specific Antigens
  Expert Opinion on Pharmacotherapy. Oct, 2014  |   Pubmed ID: 25139628
• Immunological Targeting of Cytomegalovirus for Glioblastoma Therapy
  Oncoimmunology. 2014  |   Pubmed ID: 25101224
• A Novel, Reproducible, and Objective Method for Volumetric Magnetic Resonance Imaging Assessment of Enhancing Glioblastoma
  Journal of Neurosurgery. Sep, 2014  |   Pubmed ID: 25036205
• Oncolytic Polio Virotherapy of Cancer
  Cancer. Nov, 2014  |   Pubmed ID: 24939611
• Worse Outcomes for Patients Undergoing Brain Tumor and Cerebrovascular Procedures Following the ACGME Resident Duty-hour Restrictions
  Journal of Neurosurgery. Aug, 2014  |   Pubmed ID: 24926647
• Response
  Journal of Neurosurgery. Mar, 2014  |   Pubmed ID: 24724172
• EGFRvIII-specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma
  PloS One. 2014  |   Pubmed ID: 24722266
• Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus Pp65-specific Cytotoxic T Cells
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2014  |   Pubmed ID: 24658154
• Methodology and Reporting of Meta-analyses in the Neurosurgical Literature
  Journal of Neurosurgery. Apr, 2014  |   Pubmed ID: 24460491
• Editorial on "heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: a Phase II, Single Arm Trial"
  Neuro-oncology. Jan, 2014  |   Pubmed ID: 24443362
• Impact of PhD Training on Scholarship in a Neurosurgical Career
  Journal of Neurosurgery. Mar, 2014  |   Pubmed ID: 24359004
• EGFRvIII MCAR-modified T-cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity Against Tumor-antigen Loss
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2014  |   Pubmed ID: 24352643
• SEER Insights
  Journal of Neurosurgery. Feb, 2014  |   Pubmed ID: 24286150
• Intracerebral Delivery of a Third Generation EGFRvIII-specific Chimeric Antigen Receptor is Efficacious Against Human Glioma
  Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. Jan, 2014  |   Pubmed ID: 24054399
• Human Regulatory T Cells Kill Tumor Cells Through Granzyme-dependent Cytotoxicity Upon Retargeting with a Bispecific Antibody
  Cancer Immunology Research. Sep, 2013  |   Pubmed ID: 24570975
• Regulatory T Cells Are Redirected to Kill Glioblastoma by an EGFRvIII-targeted Bispecific Antibody
  Oncoimmunology. Dec, 2013  |   Pubmed ID: 24475376
• Enhanced Oncolytic Virotherapy Through Oxidative Stress Inhibition
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2013  |   Pubmed ID: 24201213
• A Cytokine Cocktail Directly Modulates the Phenotype of DC-enriched Anti-tumor T Cells to Convey Potent Anti-tumor Activities in a Murine Model
  Cancer Immunology, Immunotherapy : CII. Nov, 2013  |   Pubmed ID: 23982483
• An EGFRvIII-targeted Bispecific T-cell Engager Overcomes Limitations of the Standard of Care for Glioblastoma
  Expert Review of Clinical Pharmacology. Jul, 2013  |   Pubmed ID: 23927666
• Antibody, T-cell and Dendritic Cell Immunotherapy for Malignant Brain Tumors
  Future Oncology (London, England). Jul, 2013  |   Pubmed ID: 23837761
• Rational Design and Generation of Recombinant Control Reagents for Bispecific Antibodies Through CDR Mutagenesis
  Journal of Immunological Methods. Sep, 2013  |   Pubmed ID: 23806556
• Complete Response to Steroids in Dural Inflammatory Pseudotumor Associated with Still's Disease
  Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. Oct, 2013  |   Pubmed ID: 23768965
• An Update on Vaccine Therapy and Other Immunotherapeutic Approaches for Glioblastoma
  Expert Review of Vaccines. Jun, 2013  |   Pubmed ID: 23750791
• A Novel Bispecific Antibody Recruits T Cells to Eradicate Tumors in the "immunologically Privileged" Central Nervous System
  Oncoimmunology. Apr, 2013  |   Pubmed ID: 23734318
• Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: a Prospective Trial
  International Journal of Radiation Oncology, Biology, Physics. Aug, 2013  |   Pubmed ID: 23725997
• Clinicopathological Characteristics and Treatment of Rhabdoid Glioblastoma
  Journal of Neurosurgery. Aug, 2013  |   Pubmed ID: 23641829
• Radiotherapy and Radiosurgery for Tumors of the Central Nervous System
  Surgical Oncology Clinics of North America. Jul, 2013  |   Pubmed ID: 23622073
• BLyS Levels Correlate with Vaccine-induced Antibody Titers in Patients with Glioblastoma Lymphodepleted by Therapeutic Temozolomide
  Cancer Immunology, Immunotherapy : CII. Jun, 2013  |   Pubmed ID: 23591978
• Isocitrate Dehydrogenase 1: What It Means to the Neurosurgeon: a Review
  Journal of Neurosurgery. Jun, 2013  |   Pubmed ID: 23581583
• Myeloablative Temozolomide Enhances CD8⁺ T-cell Responses to Vaccine and is Required for Efficacy Against Brain Tumors in Mice
  PloS One. 2013  |   Pubmed ID: 23527092
• Thickness of Subcutaneous Fat As a Risk Factor for Infection in Cervical Spine Fusion Surgery
  The Journal of Bone and Joint Surgery. American Volume. Feb, 2013  |   Pubmed ID: 23426766
• Systemic Administration of a Bispecific Antibody Targeting EGFRvIII Successfully Treats Intracerebral Glioma
  Proceedings of the National Academy of Sciences of the United States of America. Jan, 2013  |   Pubmed ID: 23248284
• Subarachnoid Hemorrhage Trials
  Journal of Neurosurgery. Jan, 2013  |   Pubmed ID: 23039153
• Contemporary Surgical Management of Vestibular Schwannomas: Analysis of Complications and Lessons Learned over the Past Decade
  Neurosurgery. Jun, 2013  |   Pubmed ID: 23037828
• Therapeutic Approaches for HER2-positive Brain Metastases: Circumventing the Blood-brain Barrier
  Cancer Treatment Reviews. May, 2013  |   Pubmed ID: 22727691
• The Limitations of Imaging Response Criteria
  The Lancet. Oncology. Nov, 2012  |   Pubmed ID: 23116995
• Regulatory T Cells Move in when Gliomas Say "I Do"
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2012  |   Pubmed ID: 23052252
• Enzyme Redesign Guided by Cancer-derived IDH1 Mutations
  Nature Chemical Biology. Nov, 2012  |   Pubmed ID: 23001033
• Editorial: Convection-enhanced Delivery
  Journal of Neurosurgery. Dec, 2012  |   Pubmed ID: 22998062
• Stereotactic Radiosurgery and Bevacizumab for Recurrent Glioblastoma Multiforme
  Journal of the National Comprehensive Cancer Network : JNCCN. Jun, 2012  |   Pubmed ID: 22679114
• The Use of Motor Mapping to Aid Resection of Eloquent Gliomas
  Neurosurgery Clinics of North America. Apr, 2012  |   Pubmed ID: 22440865
• Resection and Survival
  Journal of Neurosurgery. Jun, 2012  |   Pubmed ID: 22424561
• Phase 1 Trial of Dasatinib Plus Erlotinib in Adults with Recurrent Malignant Glioma
  Journal of Neuro-oncology. Jul, 2012  |   Pubmed ID: 22407177
• Toxin-based Targeted Therapy for Malignant Brain Tumors
  Clinical & Developmental Immunology. 2012  |   Pubmed ID: 22400035
• A Pilot Study of IL-2Rα Blockade During Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
  PloS One. 2012  |   Pubmed ID: 22383993
• Convection Enhanced Delivery of Macromolecules for Brain Tumors
  Current Drug Discovery Technologies. Dec, 2012  |   Pubmed ID: 22339074
• Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
  Current Drug Discovery Technologies. Dec, 2012  |   Pubmed ID: 22339070
• Clinical Data Simplified
  Journal of Neurosurgery. Feb, 2012  |   Pubmed ID: 22054209
• Avastin: More Questions Than Answers. .
  Journal of Neurosurgery. Feb, 2012  |   Pubmed ID: 22035270
• Phase II Study of Carboplatin, Irinotecan, and Bevacizumab for Bevacizumab Naïve, Recurrent Glioblastoma
  Journal of Neuro-oncology. Mar, 2012  |   Pubmed ID: 21986722
• Phase II Study of Gleevec® Plus Hydroxyurea (HU) in Adults with Progressive or Recurrent Meningioma
  Journal of Neuro-oncology. Jan, 2012  |   Pubmed ID: 21938530
• Disparities in Care
  Journal of Neurosurgery. Feb, 2012  |   Pubmed ID: 21740120
• Application of Novel Response/progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
  Neurosurgery. Jan, 2012  |   Pubmed ID: 21593697
• Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients with Recurrent Malignant Gliomas
  International Journal of Radiation Oncology, Biology, Physics. Apr, 2012  |   Pubmed ID: 21489708
• Imaging of Convection Enhanced Delivery of Toxins in Humans
  Toxins. Mar, 2011  |   Pubmed ID: 22069706
• Monitoring Radiographic Brain Tumor Progression
  Toxins. Mar, 2011  |   Pubmed ID: 22069705
• Bevacizumab-induced Reversible Posterior Leukoencephalopathy Syndrome and Successful Retreatment in a Patient with Glioblastoma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2011  |   Pubmed ID: 21900098
• Monoclonal Antibody Blockade of IL-2 Receptor α During Lymphopenia Selectively Depletes Regulatory T Cells in Mice and Humans
  Blood. Sep, 2011  |   Pubmed ID: 21768296
• Is Cytomegalovirus a Therapeutic Target in Glioblastoma?
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2011  |   Pubmed ID: 21632859
• Convection-enhanced Delivery
  Journal of Neurosurgery. Sep, 2011  |   Pubmed ID: 21619413
• Phase 2 Study of Carboplatin, Irinotecan, and Bevacizumab for Recurrent Glioblastoma After Progression on Bevacizumab Therapy
  Cancer. Dec, 2011  |   Pubmed ID: 21590689
• Our Failure to Advance New Treatments for Glioma to Market
  Journal of Neurosurgery. Aug, 2011  |   Pubmed ID: 21568655
• The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2011  |   Pubmed ID: 21531816
• Epidemiology
  Journal of Neurosurgery. Aug, 2011  |   Pubmed ID: 21529133
• A Review of VEGF/VEGFR-targeted Therapeutics for Recurrent Glioblastoma
  Journal of the National Comprehensive Cancer Network : JNCCN. Apr, 2011  |   Pubmed ID: 21464146
• Bispecific Antibodies Engage T Cells for Antitumor Immunotherapy
  Expert Opinion on Biological Therapy. Jul, 2011  |   Pubmed ID: 21449821
• Colocalization of Gadolinium-diethylene Triamine Pentaacetic Acid with High-molecular-weight Molecules After Intracerebral Convection-enhanced Delivery in Humans
  Neurosurgery. Sep, 2011  |   Pubmed ID: 21430586
• Clinical Trial End Points for High-grade Glioma: the Evolving Landscape
  Neuro-oncology. Mar, 2011  |   Pubmed ID: 21310734
• A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors
  PloS One. 2011  |   Pubmed ID: 21298088
• Resection of Vestibular Schwannomas
  Journal of Neurosurgery. May, 2011  |   Pubmed ID: 21250806
• Greater Chemotherapy-induced Lymphopenia Enhances Tumor-specific Immune Responses That Eliminate EGFRvIII-expressing Tumor Cells in Patients with Glioblastoma
  Neuro-oncology. Mar, 2011  |   Pubmed ID: 21149254
• Immunotherapy Coming of Age: What Will It Take to Make It Standard of Care for Glioblastoma?
  Neuro-oncology. Jan, 2011  |   Pubmed ID: 21149252
• A Comprehensive Outlook on Intracerebral Therapy of Malignant Gliomas
  Critical Reviews in Oncology/hematology. Oct, 2011  |   Pubmed ID: 20888252
• Low-grade Glioma
  Journal of Neurosurgery. Mar, 2011  |   Pubmed ID: 20635855
• Effect of Imaging and Catheter Characteristics on Clinical Outcome for Patients in the PRECISE Study
  Journal of Neuro-oncology. Jan, 2011  |   Pubmed ID: 20563833
• Effect of CYP3A-inducing Anti-epileptics on Sorafenib Exposure: Results of a Phase II Study of Sorafenib Plus Daily Temozolomide in Adults with Recurrent Glioblastoma
  Journal of Neuro-oncology. Jan, 2011  |   Pubmed ID: 20443129
• Immunologic Escape After Prolonged Progression-free Survival with Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients with Newly Diagnosed Glioblastoma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2010  |   Pubmed ID: 20921459
• Stereotactic Radiosurgery in the Treatment of a Dural Carotid-cavernous Fistula
  Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. Jun, 2010  |   Pubmed ID: 20431489
• Immunotherapy Approaches for Malignant Glioma from 2007 to 2009
  Current Neurology and Neuroscience Reports. Jul, 2010  |   Pubmed ID: 20424975
• Long-term Safety of Combined Intracerebral Delivery of Free Gadolinium and Targeted Chemotherapeutic Agent PRX321
  Neurological Research. Oct, 2010  |   Pubmed ID: 20021739
• Poor Drug Distribution As a Possible Explanation for the Results of the PRECISE Trial
  Journal of Neurosurgery. Aug, 2010  |   Pubmed ID: 20020841
• Bevacizumab Fails to Treat Temporal Paraganglioma: Discussion and Case Illustration
  Journal of Neuro-oncology. Jul, 2010  |   Pubmed ID: 20020179
• The Role of Tregs in Glioma-mediated Immunosuppression: Potential Target for Intervention
  Neurosurgery Clinics of North America. Jan, 2010  |   Pubmed ID: 19944972
• Clinical Applications of a Peptide-based Vaccine for Glioblastoma
  Neurosurgery Clinics of North America. Jan, 2010  |   Pubmed ID: 19944970
• Convection-enhanced Delivery of Free Gadolinium with the Recombinant Immunotoxin MR1-1
  Journal of Neuro-oncology. May, 2010  |   Pubmed ID: 19898744
• Phase 2 Trial of Erlotinib Plus Sirolimus in Adults with Recurrent Glioblastoma
  Journal of Neuro-oncology. Jan, 2010  |   Pubmed ID: 19562254
• The Role of Tregs in Human Glioma Patients and Their Inhibition with a Novel STAT-3 Inhibitor
  Clinical Neurosurgery. 2009  |   Pubmed ID: 20214040
• An Epidermal Growth Factor Receptor Variant III-targeted Vaccine is Safe and Immunogenic in Patients with Glioblastoma Multiforme
  Molecular Cancer Therapeutics. Oct, 2009  |   Pubmed ID: 19825799
• EGFRvIII-targeted Vaccination Therapy of Malignant Glioma
  Brain Pathology (Zurich, Switzerland). Oct, 2009  |   Pubmed ID: 19744042
• Treatment of HER2-positive Breast Carcinomatous Meningitis with Intrathecal Administration of Alpha-particle-emitting (211)At-labeled Trastuzumab
  Nuclear Medicine and Biology. Aug, 2009  |   Pubmed ID: 19647172
• The PEPvIII-KLH (CDX-110) Vaccine in Glioblastoma Multiforme Patients
  Expert Opinion on Biological Therapy. Aug, 2009  |   Pubmed ID: 19591631
• Toward Effective Immunotherapy for the Treatment of Malignant Brain Tumors
  Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Jul, 2009  |   Pubmed ID: 19560742
• Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults with Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy
  Journal of Neuro-oncology. Dec, 2009  |   Pubmed ID: 19533023
• A Constitutively Active Form of Neurokinin 1 Receptor and Neurokinin 1 Receptor-mediated Apoptosis in Glioblastomas
  Journal of Neurochemistry. May, 2009  |   Pubmed ID: 19519779
• Paraganglioma of the Head and Neck: Long-term Local Control with Radiotherapy
  American Journal of Clinical Oncology. Jun, 2009  |   Pubmed ID: 19433962
• IgE, Allergy, and Risk of Glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide Era
  International Journal of Cancer. Journal International Du Cancer. Aug, 2009  |   Pubmed ID: 19408307
• Phase 1 Trial of Temozolomide Plus Irinotecan Plus O6-benzylguanine in Adults with Recurrent Malignant Glioma
  Cancer. Jul, 2009  |   Pubmed ID: 19402172
• Phase I Trial of Temozolomide Plus O6-benzylguanine 5-day Regimen with Recurrent Malignant Glioma
  Neuro-oncology. Oct, 2009  |   Pubmed ID: 19289491
• Phase II Trial of Temozolomide Plus O6-benzylguanine in Adults with Recurrent, Temozolomide-resistant Malignant Glioma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2009  |   Pubmed ID: 19204199
• Phase II Trial of Gliadel Plus O6-benzylguanine in Adults with Recurrent Glioblastoma Multiforme
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2009  |   Pubmed ID: 19188181
• Proteomic and Immunologic Analyses of Brain Tumor Exosomes
  FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. May, 2009  |   Pubmed ID: 19109410
• Stereotactic Body Radiotherapy for Lesions of the Spine and Paraspinal Regions
  International Journal of Radiation Oncology, Biology, Physics. Apr, 2009  |   Pubmed ID: 19004569
• A Novel Inhibitor of Signal Transducers and Activators of Transcription 3 Activation is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2008  |   Pubmed ID: 18794085
• Detection of Humoral Response in Patients with Glioblastoma Receiving EGFRvIII-KLH Vaccines
  Journal of Immunological Methods. Nov, 2008  |   Pubmed ID: 18775433
• Tumor-specific Immunotherapy Targeting the EGFRvIII Mutation in Patients with Malignant Glioma
  Seminars in Immunology. Oct, 2008  |   Pubmed ID: 18539480
• Combating Immunosuppression in Glioma
  Future Oncology (London, England). Jun, 2008  |   Pubmed ID: 18518768
• Immunotherapy Against Angiogenesis-associated Targets: Evidence and Implications for the Treatment of Malignant Glioma
  Expert Review of Anticancer Therapy. May, 2008  |   Pubmed ID: 18471045
• Selective Modification of Antigen-specific T Cells by RNA Electroporation
  Human Gene Therapy. May, 2008  |   Pubmed ID: 18471037
• Intracerebral Infusion of an EGFR-targeted Toxin in Recurrent Malignant Brain Tumors
  Neuro-oncology. Jun, 2008  |   Pubmed ID: 18403491
• Cryptococcal Meningitis in Patients with Glioma: a Report of Two Cases
  Journal of Neuro-oncology. Aug, 2008  |   Pubmed ID: 18398572
• Immunotherapy of Malignant Brain Tumors
  Immunological Reviews. Apr, 2008  |   Pubmed ID: 18363995
• Cholesterol Granuloma of the Lateral Ventricle. Case Report
  Journal of Neurosurgery. Feb, 2008  |   Pubmed ID: 18240934
• Immunological Responses in a Patient with Glioblastoma Multiforme Treated with Sequential Courses of Temozolomide and Immunotherapy: Case Study
  Neuro-oncology. Feb, 2008  |   Pubmed ID: 18079360
• Sensitive Detection of Human Cytomegalovirus in Tumors and Peripheral Blood of Patients Diagnosed with Glioblastoma
  Neuro-oncology. Feb, 2008  |   Pubmed ID: 17951512
• EGFRvIII-targeted Immunotoxin Induces Antitumor Immunity That is Inhibited in the Absence of CD4+ and CD8+ T Cells
  Cancer Immunology, Immunotherapy : CII. Jan, 2008  |   Pubmed ID: 17634939
• Convection-enhanced Delivery of Cintredekin Besudotox (interleukin-13-PE38QQR) Followed by Radiation Therapy with and Without Temozolomide in Newly Diagnosed Malignant Gliomas: Phase 1 Study of Final Safety Results
  Neurosurgery. Nov, 2007  |   Pubmed ID: 18091279
• Clinical Utility of a Patient-specific Algorithm for Simulating Intracerebral Drug Infusions
  Neuro-oncology. Jul, 2007  |   Pubmed ID: 17435179
• Viruses in the Treatment of Malignant Glioma
  Expert Review of Neurotherapeutics. Apr, 2007  |   Pubmed ID: 17425484
• Systemic CTLA-4 Blockade Ameliorates Glioma-induced Changes to the CD4+ T Cell Compartment Without Affecting Regulatory T-cell Function
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2007  |   Pubmed ID: 17404100
• Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: a Report by the Cintredekin Besudotox Intraparenchymal Study Group
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2007  |   Pubmed ID: 17327604
• Induction of Hyperintense Signal on T2-weighted MR Images Correlates with Infusion Distribution from Intracerebral Convection-enhanced Delivery of a Tumor-targeted Cytotoxin
  AJR. American Journal of Roentgenology. Mar, 2007  |   Pubmed ID: 17312057
• Intracerebral Infusate Distribution by Convection-enhanced Delivery in Humans with Malignant Gliomas: Descriptive Effects of Target Anatomy and Catheter Positioning
  Neurosurgery. Feb, 2007  |   Pubmed ID: 17297371
• Phase II Study of Imatinib Mesylate and Hydroxyurea for Recurrent Grade III Malignant Gliomas
  Journal of Neuro-oncology. May, 2007  |   Pubmed ID: 17245623
• Genetic Analysis of Intracranial Tumors in a Murine Model of Glioma Demonstrate a Shift in Gene Expression in Response to Host Immunity
  Journal of Neuroimmunology. Jan, 2007  |   Pubmed ID: 17137636
• Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2006  |   Pubmed ID: 17189402
• Treatment of Neoplastic Meningitis with Intrathecal 9-nitro-camptothecin
  Neurologia Medico-chirurgica. Oct, 2006  |   Pubmed ID: 17062987
• Preoperative Functional MR Imaging Localization of Language and Motor Areas: Effect on Therapeutic Decision Making in Patients with Potentially Resectable Brain Tumors
  Radiology. Sep, 2006  |   Pubmed ID: 16857981
• Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma Without Eliminating Regulatory T Cells
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2006  |   Pubmed ID: 16857805
• Novel Human IgG2b/murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with 131I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jun, 2006  |   Pubmed ID: 16741299
• Safety of Intraparenchymal Convection-enhanced Delivery of Cintredekin Besudotox in Early-phase Studies
  Neurosurgical Focus. 2006  |   Pubmed ID: 16709020
• Comparison of Intratumoral Bolus Injection and Convection-enhanced Delivery of Radiolabeled Antitenascin Monoclonal Antibodies
  Neurosurgical Focus. 2006  |   Pubmed ID: 16709019
• Convection-enhanced Delivery of Therapeutics for Brain Disease, and Its Optimization
  Neurosurgical Focus. 2006  |   Pubmed ID: 16709017
• Increased Regulatory T-cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma
  Cancer Research. Mar, 2006  |   Pubmed ID: 16540683
• Targeted Therapy for Glioblastoma Multiforme Neoplastic Meningitis with Intrathecal Delivery of an Oncolytic Recombinant Poliovirus
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2006  |   Pubmed ID: 16489093
• Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2006  |   Pubmed ID: 16467100
• Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults with Recurrent Glioblastoma Multiforme
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Dec, 2005  |   Pubmed ID: 16361636
• Phase I Trial of Temozolomide Plus O6-benzylguanine for Patients with Recurrent or Progressive Malignant Glioma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2005  |   Pubmed ID: 16192602
• Surgical Management of Petroclival Meningiomas: Defining Resection Goals Based on Risk of Neurological Morbidity and Tumor Recurrence Rates in 137 Patients
  Neurosurgery. Mar, 2005  |   Pubmed ID: 15730581
• Sustained Radiographic and Clinical Response in Patient with Bifrontal Recurrent Glioblastoma Multiforme with Intracerebral Infusion of the Recombinant Targeted Toxin TP-38: Case Study
  Neuro-oncology. Jan, 2005  |   Pubmed ID: 15701286
• Poliovirus Receptor CD155-targeted Oncolysis of Glioma
  Neuro-oncology. Jul, 2004  |   Pubmed ID: 15279713
• Treatment of Intracerebral Neoplasia and Neoplastic Meningitis with Regional Delivery of Oncolytic Recombinant Poliovirus
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2004  |   Pubmed ID: 15269159
• Phase 1 Trial of Irinotecan Plus BCNU in Patients with Progressive or Recurrent Malignant Glioma
  Neuro-oncology. Apr, 2004  |   Pubmed ID: 15134629
• Phase 2 Trial of BCNU Plus Irinotecan in Adults with Malignant Glioma
  Neuro-oncology. Apr, 2004  |   Pubmed ID: 15134628
• Resistance to Tyrosine Kinase Inhibition by Mutant Epidermal Growth Factor Receptor Variant III Contributes to the Neoplastic Phenotype of Glioblastoma Multiforme
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2004  |   Pubmed ID: 15131063
• Microvascular Decompression for Glossopharyngeal Neuralgia: Long-term Effectiveness and Complication Avoidance
  Neurosurgery. Apr, 2004  |   Pubmed ID: 15046654
• Immunotherapy of Surgical Malignancies
  Current Problems in Surgery. Jan, 2004  |   Pubmed ID: 14749625
• Phase II Trial of Gefitinib in Recurrent Glioblastoma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jan, 2004  |   Pubmed ID: 14638850
• Efficacy of Intracerebral Microinfusion of Trastuzumab in an Athymic Rat Model of Intracerebral Metastatic Breast Cancer
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2003  |   Pubmed ID: 14654531
• Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-alpha and a Mutated Form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors
  Journal of Neuro-oncology. Oct, 2003  |   Pubmed ID: 14649883
• Epidermal Growth Factor Receptor VIII Peptide Vaccination is Efficacious Against Established Intracerebral Tumors
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2003  |   Pubmed ID: 14519652
• Adoptive Immunotherapy for Malignant Glioma
  Cancer Journal (Sudbury, Mass.). May-Jun, 2003  |   Pubmed ID: 12952301
• The History, Evolution, and Clinical Use of Dendritic Cell-based Immunization Strategies in the Therapy of Brain Tumors
  Journal of Neuro-oncology. Aug-Sep, 2003  |   Pubmed ID: 12952297
• Phase II Trial of Temozolomide in Patients with Progressive Low-grade Glioma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2003  |   Pubmed ID: 12586801
• Clinical Immunotherapy for Brain Tumors
  Neuroimaging Clinics of North America. Nov, 2002  |   Pubmed ID: 12687917
• Viruses in the Treatment of Brain Tumors
  Neuroimaging Clinics of North America. Nov, 2002  |   Pubmed ID: 12687911
• Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-tyrosine Kinase Inhibitor ZD1839 (iressa)
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2002  |   Pubmed ID: 12429640
• Intracanalicular Meningioma Mimicking Vestibular Schwannoma
  AJNR. American Journal of Neuroradiology. Oct, 2002  |   Pubmed ID: 12372737
• Mutant Epidermal Growth Factor Receptor Up-regulates Molecular Effectors of Tumor Invasion
  Cancer Research. Jun, 2002  |   Pubmed ID: 12067969
• Phase II Trial of Carmustine Plus O(6)-benzylguanine for Patients with Nitrosourea-resistant Recurrent or Progressive Malignant Glioma
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2002  |   Pubmed ID: 11980998
• Phase II Trial of Murine (131)I-labeled Antitenascin Monoclonal Antibody 81C6 Administered into Surgically Created Resection Cavities of Patients with Newly Diagnosed Malignant Gliomas
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2002  |   Pubmed ID: 11870184
• Generation of Anti-idiotypic Reagents in the EGFRvIII Tumor-associated Antigen System
  Cancer Immunology, Immunotherapy : CII. Feb, 2002  |   Pubmed ID: 11862416
• Dendritic Cells Pulsed with a Tumor-specific Peptide Induce Long-lasting Immunity and Are Effective Against Murine Intracerebral Melanoma
  Neurosurgery. Jan, 2002  |   Pubmed ID: 11844246